Carlyle Group (NYSE:CG) is reportedly in exclusive talks to acquire Baxter International Inc.’s (NYSE:BAX) kidney-care ...
Private equity firm Carlyle Group is in exclusive talks to acquire Baxter International's kidney care spinoff Vantive for ...
Private equity firm Carlyle Group is reportedly in talks to acquire Baxter's kidney care spinoff for more than $4 billion.
Private-equity firm Carlyle Group is in talks to buy Baxter International's spinoff kidney business, Vantive, The Wall Street Journal reports. The sale of the business could go for more than $4 ...
Baxter is considering the sale of its kidney care business to private equity firm Carlyle Group for more than $4 billion, The Wall Street Journal reported on Friday.
Baxter stock surges 5% on news of $4 billion deal with Carlyle Group for kidney care unit, potentially ending in sale instead ...
, opens new tab kidney care spinoff Vantive for more than $4 billion, including debt, a person familiar with the matter told Reuters on Friday. Shares of the Deerfield, Illinois-based firm rose ...
(Reuters) -Private equity firm Carlyle Group is in exclusive talks to acquire Baxter International's kidney care spinoff Vantive for more than $4 billion, including debt, a person familiar with ...